Investing in disruptive, early-stage, European life sciences companies

Supporting truly transformational technologies in the Therapeutics, MedTech and Digital Health sectors

Working closely with our portfolio companies to bring healthcare innovations to market

We invest in Therapeutics, MedTech and Digital Health

Hovione Capital was founded by the shareholders of Hovione, an International Pharmaceutical Industrial Group. We invest in life sciences’ projects based in Europe, with a particular focus on Therapeutics, MedTech and Digital Health

Know More

Portfolio

We invest in early-stage life sciences companies. At Hovione Capital, we work closely with our entrepreneurs to build leading companies with technologies and products designed to positively impact people’s health. Projects must meet several critical points before we are able to invest, please see our Investment Criteria page before sending us an investment proposal.

Know more

Therapeutics, MedTech and Digital Health

We typically invest between €200,000 to €1,000,000 per project, usually bringing additional healthcare-specialized investors to the Company to add value and mitigate risk.

Our partners
Your cookie settings

We ask you to accept cookies for the purpose of performance, social networking and advertising.
For more information or correct your preferences, press the button "more info".
For more information about these cookies and the processing of your personal data, check out our cookie and Privacy Policy. Accept these cookies and the processing of personal data involved?

Accept cookies More information